Craft

Imaxio

Total Funding

$3.8 M

Imaxio Summary

Company Summary

Overview
Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis. Its products are based on an antigen re-engineering platform to improve immunogenicity, as well as to develop vaccines and immunotherapies.
Type
Private
Status
Active
Founded
2000
HQ
Paris, FR | view all locations
Website
http://www.imaxio.com
Cybersecurity rating
Sectors

Key People

  • Christian Pradeyrol, Chairman of the Board and CEO

    • Sylvain Landon, Chief Operating & Financial Officer

      • Alexandre le Vert, Board Member

        • Valérie Huertas, Qualified Person, Pharmaceutical Affairs Director and Deputy CEO

          LocationsView all

          2 locations detected

          • Paris, IDF HQ

            France

            5 Rue Saint-Roch

          • Lyon, Auvergne-Rhône-Alpes

            France

            99 Rue de Gerland

          Footer menu